Polymorphic variants within the human natural resistance-associated macrophage protein-1 (NRAMP1, also known as SLC11A1) gene have been shown to impact on susceptibility to tuberculosis in different human populations. In the mouse, Nramp1 is expressed at the macrophage phagosomal membrane and its activity can be assayed by the relative acquisition of mannose 6-phosphate receptor (M6PR) in Salmonella-containing vacuoles. Based on this M6PR recruitment assay, we have now developed an assay in primary human macrophages to test the function of human NRAMP1 gene variants. First, we established that M6PR acquisition was significantly higher (P ¼ 0.002) in human U-937 monocytic cell lines transfected with NRAMP1 as compared to untransfected U-937 cells. Second, the M6PR assay was shown to be highly reproducible for NRAMP1 activity in monocyte-derived macrophages (MDM) from healthy volunteers. Finally, the assay was investigated in MDM from pediatric tuberculosis patients and significantly lower NRAMP1 activity was detected in MDM from individuals homozygous for the NRAMP1-274 high-risk allele (CC genotype) in comparison to heterozygous individuals (CT genotype; P ¼ 0.013). The present study describes both an assay for human NRAMP1 functional activity and concomitant evidence for reduced NRAMP1 function in the common genetic variant shown to be associated with tuberculosis susceptibility in pediatric patients.
Introduction
According to recent figures, approximately 2 billion people worldwide are infected with Mycobacterium tuberculosis, the bacterium causing tuberculosis. The ongoing prevalence of tuberculosis results in nearly 9 million new tuberculosis disease cases and 2 million deaths each year. 1 In addition, there is an alarming rise in multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of M. tuberculosis, 2 which points to the urgent need to develop treatment strategies outside of the antibacterial spectrum. One avenue toward new therapeutic targets is based on identifying host genetic factors underlying susceptibility to infection.
Numerous genetic studies of tuberculosis disease have now been conducted, primarily in adults with pulmonary tuberculosis where the time lapse from infection with M. tuberculosis to clinically evident disease is unknown. Recently, we have focused on studies of primary tuberculosis disease (development of disease within 2 years of infection) on the assumption that early-and rapid-onset of tuberculosis disease may be less confounded by unmeasured environmental influences. In our studies, we have analyzed the human natural resistance-associated macrophage protein-1 gene (NRAMP1, also known as SLC11A1) as a candidate gene, as several groups have identified an impact of NRAMP1 on susceptibility to tuberculosis, as well as leprosy and inflammatory diseases. [3] [4] [5] We have identified common alleles of NRAMP1 polymorphisms as major risk factors for primary tuberculosis in two exposure settings: among previously unexposed adults in a tuberculosis disease outbreak in Northern Alberta, Canada, 6 as well as among children in a low M. tuberculosis exposure setting in Houston (TX, USA). 7 Specifically, the NRAMP1-274C
allele was identified as a major pediatric tuberculosis disease risk factor in families with low exposure intensities to M. tuberculosis.
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The NRAMP1-274C/T polymorphism corresponds to a silent nucleotide substitution in codon 66 (Phe) in exon 3 of the gene. In order to study the possible impact of the NRAMP1-274C allele on protein function, we have turned to the murine model of Nramp1 in vitro activity. Murine Nramp1 is primarily expressed at the phagosomal membrane of macrophages and functions as a pH-dependent divalent cation pump. 8, 9 A single G169D mutation in murine Nramp1 leads to loss of a mature protein and causes increased susceptibility to intracellular pathogens, such as Mycobacterium bovis bacillus Calmette-Guerin, Salmonella typhimurium and Leishmania donovani.
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These pathogens avoid host killing by sequestration in phagosomes, albeit through different evasion mechanisms. Once Salmonella species invade their host cells, the bacteria are able to modify the composition and location of their phagosomal vacuoles in the cell to form an intracellular replication niche called the Salmonella-containing vacuole (SCV). [11] [12] [13] The lateendosomal/lysosomal marker mannose 6-phosphate receptor (M6PR) is largely excluded from vacuoles containing live Salmonella bacteria. 14, 15 However, there is greater recruitment of the M6PR to the SCV in Nramp1-expressing murine macrophages compared with nonexpressing cells. Therefore, the influence of Nramp1 on recruitment provides a quantitative measure of Nramp1 activity. 14 In the present study, we have adapted the recruitment of M6PR to the SCV in human macrophages as a measure of NRAMP1 activity. Specifically, we have developed the SCV-M6PR assay in macrophages derived from blood as a method to study the impact on NRAMP1 function of known genetic variants. The results suggest that the NRAMP1-274C allele may be linked with low innate macrophage function.
Results

Expression of NRAMP1 in U-937 cells
The first series of experiments were undertaken in the human monocytic cell line U-937, both untransfected and stably expressing an NRAMP1-c-Myc-tagged construct (U-937 þ NRAMP1), to establish assay parameters. The level of NRAMP1 mRNA expression in both cell types was determined before and after PMA treatment of U-937 cells, which is required for differentiation and adhesion of U-937 cells. [16] [17] [18] In wild-type U-937 cells there was no NRAMP1 expression in PMA nonstimulated cells and very low expression after PMA stimulation. In contrast, there was strong NRAMP1 expression in U-937 transfectants both before and after PMA stimulation as shown by PCR (Figure 1) . The results of the mRNA expression studies were confirmed by immunolabeling with an NRAMP1-specific antibody. Employing immunofluorescence microscopy, wild-type U-937 expressed no or very low levels of NRAMP1, while U-937 þ NRAMP1 PMA-stimulated cells expressed clearly detectable levels of c-Myc-NRAMP1 protein ( Figure 2 ).
Recruitment of Salmonella with the late-endosomal marker LAMP1 and NRAMP1 in U-937 cells
In these experiments, we tested the intracellular localization of NRAMP1-c-Myc protein in the U-937 transfectants. U-937 cells were infected with S. typhimurium and SCVs were identified by green fluorescent protein (GFP)-expressing Salmonella. NRAMP1-SCV recruitment was compared with the SCV marker lysosomal-associated membrane protein-1 (LAMP1), a late-endosomal/lyso- An in vitro assay for functional activity of human NRAMP1 CJ Gallant et al somal protein. 14, 19 LAMP1 was immunolabeled with anti-LAMP1 and NRAMP1 was detected with an antic-Myc antibody since the use of NRAMP1 antibodies did not produce a signal of sufficient strength for recruitment experiments. Salmonella bacteria were verified to be internalized by immunolabeling extracellular bacteria with anti-LPS antibodies in the absence of host cell permeabilization. After immunolabeling the cells, we measured recruitment of LAMP1 and NRAMP1 to the GFP-expressing SCV in PMA-differentiated U-937 and U-937 þ NRAMP1 cells (Figure 2 ). We found in four independent experiments that LAMP1 co-localized with 73.871.7% of SCV in U-937 cells and 72.971.7% in U-937 þ NRAMP1 cells. To obtain an estimate of NRAMP1 recruitment to the SCV in U-937 þ NRAMP1 cells, recruitment was quantified between the SCV and cMyc-tagged NRAMP1 in five independent experiments. The majority (70.972.7%) of SCVs in PMA-stimulated U-937 þ NRAMP1 cells show NRAMP1 recruitment ( Figure 2 ). Nearly identical recruitment of LAMP1 to the SCV in U-937 and U-937 þ NRAMP1 cells, and the efficient recruitment of NRAMP1 to the SCV suggest that overexpression of NRAMP1 does not cause a generalized deregulation of endocytic vesicle trafficking.
Recruitment of Salmonella with the late-endosomal marker M6PR in U-937 cells
We assayed the number of phagocytosed GFP-expressing Salmonella that co-localize with M6PR in human PMAdifferentiated wild-type U-937 and NRAMP1 transfectants. Care was taken to analyze host cells that had phagocytosed only 1-3 Salmonella bacteria. Quantification of M6PR recruitment to SCV was done by counting at least 100 internalized bacteria per experiment in seven independent experiments. As in the LAMP1/NRAMP1 recruitment experiments, Salmonella bacteria were confirmed to be internalized by immunolabeling of extracellular bacteria with anti-LPS antibodies. Subsequently, U-937 wild-type and NRAMP1 transfectant cells were permeabilized and the proportion of SCV that had recruited M6PR was determined. A significantly higher percentage of recruitment between Salmonella and M6PR was reproducibly obtained in PMA-differentiated U-937 þ NRAMP1 cells (34.072.9%) as compared to U-937 wild-type cells (21.372.42%, P ¼ 0.0002) (Figure 3 ).
Salmonella growth assay in U-937 cells We next asked if there were differences in intracellular Salmonella growth in PMA-differentiated U-937 þ NRAMP1 tranfectants and U-937 wild-type cells. In six independent experiments, PMA-differentiated U-937 and U-937 þ NRAMP1 cells were infected with Salmonella grown to late-log phase and colony forming units (CFU) were determined at 0 and 24 h postinfection. The differences in Salmonella growth were measured as log CFU 24-0 h for U-937 and U-937 þ NRAMP1 cells. In U-937 cells, Salmonella consistently showed growth at 24 h postinfection. In comparison, U-937 þ NRAMP1 cells either maintained their bacterial load (similar number of CFU at 0 and 24 h post infection) or showed bacterial clearance (P ¼ 0.0052; Figure 4 ). Taken together with the M6PR recruitment studies, these results demonstrated that both M6PR recruitment and Salmonella survival are modulated by the NRAMP1 protein.
Recruitment of Salmonella bacteria with the late-endosomal marker M6PR in monocyte-derived macrophages (MDM) from healthy volunteers In the next series of experiments, we tested if recruitment of M6PR to the SCV could also be detected in primary macrophage explants. We obtained MDM from blood of healthy volunteers and normalized the number of cells per well before they were infected with GFP-expressing Salmonella bacteria at an approximate MOI 100:1. As in the U-937 þ NRAMP1 transfectant system, a relatively weak immunofluorescence signal obtained with NRAMP1 antibodies precluded the determination of NRAMP1 recruitment. Recruitment of M6PR with the SCV was determined as for the U-937 cell experiments. We observed recruitment of M6PR to the SCV in MDM obtained from all five donors with experiments repeated at least twice for each donor. Overall, there was good inter-experimental reproducibility of M6PR recruitment by cells from the same donor suggesting that the observed differences in M6PR recruitment reflected intrinsic properties of the MDM (Table 1) . Interestingly, recruitment efficiencies of M6PR to SCV in MDM from donors with the NRAMP1-274CC genotype did not overlap with those obtained in MDM from NRAMP1-274CT and NRAMP1-274TT donors.
Recruitment of Salmonella with the late-endosomal marker M6PR in MDM from pediatric tuberculosis patients In a previous study, we had shown that among pediatric tuberculosis disease patients, NRAMP1 was a strong risk factor for tuberculosis disease. Specifically, we showed that the NRAMP1-274C allele predisposed to tubercu- An in vitro assay for functional activity of human NRAMP1 CJ Gallant et al losis disease among simplex families with an odds ratio of 3.13 (95% CI: 1.54-6.25). We therefore applied the M6PR assay to MDM from pediatric tuberculosis patients to test if risk alleles correlated with reduced functional NRAMP1 activity. We were able to obtain a second blood sample from 10 pediatric tuberculosis disease patients enrolled in the initial genetic study. In total, we successfully derived and infected MDM of nine patients with GFP-Salmonella and determined the level of M6PR recruitment to the SCV for each individual.
The NRAMP1 genotype for each patient was obtained only after M6PR/SCV recruitment had been determined for all samples. None of the patients carried a homozygous protective NRAMP1-274TT genotype. Hence, patients were assigned to two groups: those that were homozygous for the high-risk C allele (CC) and those that were heterozygous (TC). There was a significant difference in M6PR recruitment to the SCV between both groups (P ¼ 0.0129; Figure 5 ). Individuals homozygous for the high-risk NRAMP1-274C allele recruited 29.071.0% while heterozygote 274CT individuals on average showed significantly higher recruitment of 34.871.5%. Representative experiments of SCVs recruit- An in vitro assay for functional activity of human NRAMP1 CJ Gallant et al ing M6PR in MDM from the pediatric tuberculosis patients are shown in Figure 5 . There was no discernible difference of genotype or M6PR recruitment between Black and Hispanic children; that is, of the five NRAMP1-274CC homozygotes, two were Black and three were Hispanic and M6PR recruitment overlapped between cells obtained from children of both ethnic backgrounds.
Discussion
The human NRAMP1 gene has been implicated with greater risk of tuberculosis disease by a number of studies and polymorphisms within NRAMP1 have now been linked or associated with susceptibility to tuberculosis in at least 10 independent populations. 4, 6, 7, [20] [21] [22] [23] [24] [25] [26] The focus of most studies was on susceptibility to smearpositive tuberculosis disease among adult populations. In order to dissect the genetic contribution to the onset of tuberculosis disease, we had previously analyzed the effect NRAMP1 alleles had on risk of primary tuberculosis disease in a sample of pediatric patients from Houston (TX, USA). We identified the common NRAMP1-274C allele as major risk factor for early-onset pediatric tuberculosis. 7 Importantly, this finding replicated the results of the genetic analysis in an outbreak of primary tuberculosis among previously unexposed Canadian aboriginals. 6 Considering that approximately half of all tuberculosis disease cases qualify as primary tuberculosis, a better understanding of NRAMP1 function is of critical importance.
The mechanism by which human NRAMP1 disease associated variants impact on NRAMP1 activity, and how this altered activity is translated into increased disease risk is presently unknown. Murine Nramp1, found in the membranes of the late endosome/lysosome, influences phagosome maturation in both Salmonellaand Mycobacteria-infected cells. 14, 27 However, the impact of Nramp1 on phagosome maturation is likely a secondary effect of its function as a metal transporter across the phagosomal membrane. 9, 28 Here, we show that in analogy to murine Nramp1, 14, 28 NRAMP1 also impacts on intracellular vacuolar trafficking as revealed by differential recruitment of M6PR to SCVs at 90 min postinfection in PMA-differentiated NRAMP1-expressing or NRAMP1-deficient U-937 cells. We used one time point to quantify recruitment as established in the murine model. In this model, a difference of recruitment efficiency of approximately 20% was detected between cell lines expressing (33%) or devoid of Nramp1 (13%). 14 It is possible that the smaller difference in recruitment between U-937 and U-937 þ NRAMP1 cells was due to background NRAMP1 expression in PMA-stimulated U-937 cells or other background differences between human and murine cells. Nevertheless, the results obtained in the human system were remarkably consistent with the mouse model and strongly support that human and murine NRAMP1 proteins impact on the same biological pathways in phagocytic cells. Importantly, these results also support that, like in murine macrophages, the extent of recruitment of M6PR to SCVs is a valid assay for quantitation of human NRAMP1 functional activity.
The biological consequence of increased NRAMP1-dependent M6PR recruitment is not clear. It is likely that increased M6PR recruitment mirrors changes in phagosomal maturation that correct the ability of Salmonella bacteria to subvert the normal degradative pathway of the phagosome to avoid killing by host cells. In addition, M6PR is an important mediator for the delivery of vacuoles containing lysosomal enzymes to the phagosome. 29 The observed difference in Salmonella bacterial growth between U-937 wild type and NRAMP1 trans- fectants supports the claim that altered vesicular trafficking, demonstrated by differential M6PR recruitment in this study, impacts on bacterial replication and survival. Further studies are required to fully elucidate the role of NRAMP1 in modulating bacterial replication by comparing intracellular growth of Mycobacteria and other pathogens. 27 Here, we provided direct evidence that primary explanted macrophages from carriers of high-risk NRAMP1 genotypes displayed a phenotype of reduced NRAMP1 function as compared to carriers of an intermediate-risk genotype. Specifically, we detected significant differences of M6PR recruitment to SCVs in MDMs from pediatric tuberculosis patients homozygous for the high-risk NRAMP1-274C allele as compared to heterozygous donors. These findings are in good agreement with the results of the genetic analysis done in this population and suggest that lower NRAMP1 activity is underlying the observed association of the NRAMP1-274C allele with risk of pediatric tuberculosis disease. 7 The detailed study of linkage disequilibrium pattern in pediatric tuberculosis patients 7 and the recent discovery that silent nucleotide changes can have substantial biological effects 30 make the NRAMP1-274C/T polymorphism a strong causative candidate for a tuberculosis susceptibility variant. Overall, the present results, once validated in larger data sets, will provide the mechanistic framework for the identification of physiological pathways that need boosting in individuals at high risk of developing primary tuberculosis disease.
Materials and methods
Subjects
Pediatric tuberculosis patients were enrolled by the Baylor College of Medicine. Clinical criteria for diagnosis have been previously described. 7 Informed consent was obtained from all study participants. Upon agreement to participate, 8-10 ml blood was obtained from 10 patients and 5 healthy controls. Of the 10 patient samples, one was lost during setup of recruitment experiments. The study received ethical clearance from the Institutional Review Board at Baylor College of Medicine, Houston, TX, USA, and the Research Ethics Committee at the Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
NRAMP1 expression
Reverse transcription (RT)-PCR and real-time PCR was performed to detect NRAMP1 expression in U-937 and U-937 þ NRAMP1 cells before and after stimulation with phorbol 12-myristate 13-acetate (PMA). RNA was isolated from the cells using a Qiagen (Mississauga, Ontario, Canada) RNeasy Mini Kit and then 2 mg RNA was reversed transcribed into cDNA. RT-PCR was performed using specific NRAMP1 primers spanning intron 2 (forward: 5 0 -GAAGATCCCCATCCCAGAC-3 0 ; reverse: 5 0 -CTTCCCTAGCCCAGCTCCT-3 0 ) as well as GAPDH primers as a control. Real-time PCR was performed on the same cDNA using a specific NRAMP1 primer and TaqMan probe spanning intron 11 (Hs00184453_m1, TaqMan Gene Expression Assay, Applied Biosystems, Foster City, CA, USA). Expression of GAPDH, TBP and 18 s genes were each tested to determine the best endogenous control (Hs99999905_m1, Hs99999910_m1, Hs99999901_s1, respectively, TaqMan Gene Expression Assay, Applied Biosystems). All three performed equally well but only GAPDH was subsequently used as an endogenous control for the expression experiments.
M6PR and GFP-S. typhimurium recruitment assay Human U-937 and U-937 cells over-expressing an NRAMP1-c-Myc-tagged construct were seeded (5 Â 10 5 cells per well) in a 12-well plate on glass cover slips. The NRAMP1 construct was made with a pCB6 plasmid and a CMV-based promoter. Transfectant clones were verified for membrane protein expression via western blot (not shown). The clone with the highest expression was chosen to be used in our study. U-937 cells carry the NRAMP1-274CC genotype. The transfected construct also carries a 'C' at the nucleotide position 274. The cells were differentiated using 20 nM PMA (Sigma-Aldrich, St Louis, MO, USA) for 48 h followed by a 24 h incubation without stimulation. The cells were grown in antibiotic-free RPMI 1640 supplemented with 10% fetal calf serum (inactivated, endotoxin tested), 2 mM L-glutamine and 1 mM sodium pyruvate (Invitrogen, Burlington, Ontario, Canada). The cells were infected with Salmonella enterica serovar Typhimurium (Salmonella) containing a plasmid expressing the GFP. The bacteria were grown in Luria-Bertani broth supplemented with tetracycline (12 mg ml À1 ) overnight with shaking at 37 1C. The bacteria were subcultured at a 1:33 dilution for 3 h at 37 1C to late-log phase. After harvesting by centrifugation, the bacteria were washed with phosphate-buffered saline (PBS) and resuspended in Earle's buffered saline solution (pH 7.7; Invitrogen) to give an OD 600 of approximately 0.2 before being added to the differentiated cells for 10 min at 37 1C 5% CO 2 at a multiplicity of infection of approximately 100:1. Subsequently, the cells were washed gently three times with PBS to remove noninternalized bacteria.
For experiments with MDM, a total of 8-10 ml of blood was used for each experiment. The blood was diluted 1:2 using RPMI 1640 with no supplements and layered over Ficoll-Paque (GE Healthcare, Piscataway, NJ, USA) and centrifuged for 30 min at 400 g. The layer containing the mononuclear cells was removed. The cells were washed twice with RPMI for 10 min at 100 g before being resuspended in RPMI with supplements. Mononuclear cells were seeded in 3-4 wells of a 12-well plate over glass cover slips. Macrophages were allowed to adhere overnight, washed once with both RPMI and PBS before being infected as described for U-937 cells such that a majority of infected cells phagocytosed 1-3 Salmonella bacteria.
Immediately following invasion, the cells were incubated in RPMI 1640 with supplements for 90 min at 37 1C 5% CO 2 to allow for SCV maturation. Ice-cold blocking buffer (5% normal goat serum in PBS) was added for 10 min. Extracellular Salmonella were detected using a rabbit anti-Salmonella antibody (1:300; Cortex Biochem, San Leandro, CA, USA) for 15 min followed by 20 min incubation with Alexa Fluor 350-labeled goat anti-rabbit secondary antibodies (1:500; Jackson ImmunoResearch, West Grove, PA, USA). Cells were fixed with 4% paraformaldehyde for 45 min at room temperature, and blocked and permeabilized overnight with 5% normal goat serum plus 0.2% Triton X-100 in PBS. To label late endosomes, cells were incubated the following day with a mouse anti-M6PR antibody (1:50; Affinity BioReagents, Golden, CO, USA), mouse anti-LAMP1 antibody (1:300; Developmental Studies Hybridoma Bank, Iowa City, IA, USA), mouse anti-c-Myc (1:400; BD Biosciences, Mississauga, Ontario, Canada) or rabbit anti-NRAMP1 (1:200) 31 for 1 h followed by a Cy-3-conjugated goat antimouse or anti-rabbit secondary antibody for an additional 1 h (1:500; Jackson ImmunoResearch).
Mounted glass cover slips were analyzed using conventional epifluorescent microscopy with a Â 63 oil objective. To quantify the level of recruitment between M6PR, LAMP1 or c-Myc-tagged NRAMP1 and GFPexpressing Salmonella bacteria, photos of the Salmonella (green), the M6PR or LAMP1 (red) and the extracellular Salmonella (blue) were taken in the same plane and merged using the Northern Eclipse image software (Empix Imaging Inc., Mississauga, Ontario, Canada). Extracellular bacteria were labeled to allow discrimination from phagocytosed bacteria. Only cells containing 1-3 bacteria were considered. At least 100 randomly chosen bacteria per slide were counted for each experiment.
Salmonella growth assay U-937 and U-937 þ NRAMP1 cells were seeded (2-3 Â 10 5 cells per well) in a 12-well plate. The cells were differentiated and infected as described for the M6PR and GFP-S. typhimurium recruitment assay. Following infection, cells incubated for 24 h were maintained in RPMI with 100 mg ml À1 gentamicin for 2 h and then in 10 mg ml À1 gentamicin for the remaining time. At either 0 or 24 h postinfection, cells were washed once with PBS and then lysed (1% Triton X-100/0.1% sodium dodecyl sulfate in PBS) for 5 min at RT. The lysate was serially diluted and plated on Luria-Bertani agar plates. The CFUs were counted after incubating the plates for 24 h at 37 1C. Each time point was performed in triplicate and each individual experiment was repeated six times. To accommodate experimental variation of baseline uptake of Salmonella by U-937 cells, Salmonella CFU at t ¼ 0 h was subtracted in all experiments.
Statistical analysis
The difference in mean percent recruitment of Salmonella and the endocytic marker M6PR in U-937 cells was analyzed using a paired t-test. Recruitment values are shown as the mean7standard error. The differences in Salmonella growth measured as LOG CFU 24 hÀCFU 0 h for U-937 and U-937 þ NRAMP1 cells, and M6PR recruitment among MDM obtained from carriers of different NRAMP1-274C/T genotypes were analyzed using a twotailed t-test. P-values o0.05 were considered significant.
